News - Mergers & Acquisitions, Meda


Popular Filters

Sweden’s Meda rejects Mylan’s takeover overture

Sweden’s Meda rejects Mylan’s takeover overture


After a day of rumor and speculation about a takeover approach from US generic firm Mylan, Swedish drugmaker…

GenericsMedaMergers & AcquisitionsMylan Laboratories

Meda acquires US respiratory company


Swedish drugmaker Meda (STO:MEDAA) has signed an agreement to acquire the US development company Acton…

Acton PharmaceuticalsAerospan HFAFlunisolideMedaMergers & AcquisitionsPharmaceuticalRespiratory and Pulmonary

Briefs: Depomed drops Sefelsa after CRL: Sun Pharma stalking Meda?


US specialty drugmaker Depomed (Nasdaq: DEPO) says that Food and Drug Administration issued a complete…

DepomedMedaMergers & AcquisitionsMetabolicsNorth AmericaPharmaceuticalRegulationResearchSefelsaSun Pharmaceutical Industries

Jazz Pharma sells women's health business to Meda for $95 million


US drugmaker Jazz Pharmaceuticals (Nasdaq: JAZZ) today announced a definitive agreement to sell its women's…

Jazz PharmaceuticalsMedaMergers & AcquisitionsPharmaceuticalWomen's Health

EU Commission clears KKR acquisition of Pfizer Capsugel unit; Meda says no approach from Valeant


Under European Union merger regulations, the European Commission has cleared the proposed acquisition…

CapsugelMedaMergers & AcquisitionsPfizerPharmaceuticalValeant Pharmaceuticals

Back to top